(Q71241525)

English

Double-blind cross-over study of the effect of sultosilic acid piperazine salt (A-585) and bezafibrate in primary hyperlipoproteinemia

scientific article published on 01 November 1983

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

6686778

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6686778%20AND%20SRC:MED&resulttype=core&format=json

retrieved

17 October 2019

title

Double-blind cross-over study of the effect of sultosilic acid piperazine salt (A-585) and bezafibrate in primary hyperlipoproteinemia (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

6686778

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6686778%20AND%20SRC:MED&resulttype=core&format=json

retrieved

17 October 2019

author name string

H Vinazzer

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

6686778

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6686778%20AND%20SRC:MED&resulttype=core&format=json

retrieved

17 October 2019

J C Farine

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

6686778

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6686778%20AND%20SRC:MED&resulttype=core&format=json

retrieved

17 October 2019

publication date

1 November 1983

1 reference

stated in

Europe PubMed Central

PubMed publication ID

6686778

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6686778%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

1 reference

Europe PubMed Central

PubMed publication ID

6686778

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6686778%20AND%20SRC:MED&resulttype=core&format=json

retrieved

17 October 2019

volume

49

1 reference

stated in

Europe PubMed Central

PubMed publication ID

6686778

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6686778%20AND%20SRC:MED&resulttype=core&format=json

retrieved

17 October 2019

issue

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

6686778

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6686778%20AND%20SRC:MED&resulttype=core&format=json

retrieved

17 October 2019

page(s)

109-118

1 reference

stated in

Europe PubMed Central

PubMed publication ID

6686778

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6686778%20AND%20SRC:MED&resulttype=core&format=json

retrieved

17 October 2019

Identifiers

DOI

10.1016/0021-9150(83)90188-0

1 reference

stated in

Europe PubMed Central

PubMed publication ID

6686778

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6686778%20AND%20SRC:MED&resulttype=core&format=json

retrieved

17 October 2019

PubMed publication ID

6686778

1 reference

stated in

Europe PubMed Central

PubMed publication ID

6686778

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6686778%20AND%20SRC:MED&resulttype=core&format=json

(Q71241525)

Double-blind cross-over study of the effect of sultosilic acid piperazine salt (A-585) and bezafibrate in primary hyperlipoproteinemia

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)